BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18779834)

  • 21. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
    Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
    Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
    Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
    BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
    Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
    Soufi M; Sattler AM; Kurt B; Schaefer JR
    J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
    Sánchez-Moreno C; Ordovás JM; Smith CE; Baraza JC; Lee YC; Garaulet M
    J Nutr; 2011 Mar; 141(3):380-5. PubMed ID: 21209257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.
    Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y
    Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The c.553G>T Genetic Variant of the APOA5 Gene and Altered Triglyceride Levels in the Asian Population: A Meta-Analysis of Case-Control Studies.
    He H; Lei L; Chen E; Dong J; Zhang K; Yang J
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):758-765. PubMed ID: 27813673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.
    Perez-Martinez P; Corella D; Shen J; Arnett DK; Yiannakouris N; Tai ES; Orho-Melander M; Tucker KL; Tsai M; Straka RJ; Province M; Kai CS; Perez-Jimenez F; Lai CQ; Lopez-Miranda J; Guillen M; Parnell LD; Borecki I; Kathiresan S; Ordovas JM
    Am J Clin Nutr; 2009 Jan; 89(1):391-9. PubMed ID: 19056598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
    World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of APOA1 and APOA5 polymorphisms and haplotypes with lipid parameters in a Brazilian elderly cohort.
    Furuya TK; Chen ES; Ota VK; Mazzotti DR; Ramos LR; Cendoroglo MS; Araujo LQ; Burbano RR; Smith MA
    Genet Mol Res; 2013 Feb; 12(3):3495-9. PubMed ID: 23479152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.
    Hubacek JA; Wang WW; Skodová Z; Adámková V; Vráblík M; Horínek A; Stulc T; Ceska R; Talmud PJ
    Clin Chem Lab Med; 2008; 46(6):773-7. PubMed ID: 18601597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
    Kim M; Kim M; Yoo HJ; Lee E; Chae JS; Lee SH; Lee JH
    PLoS One; 2017; 12(12):e0186693. PubMed ID: 29211729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.
    Pisciotta L; Fresa R; Bellocchio A; Guido V; Priore Oliva C; Calandra S; Bertolini S
    Clin Chim Acta; 2011 Nov; 412(23-24):2194-8. PubMed ID: 21846464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
    Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
    Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.